ABCR  Vol.2 No.4 , October 2013
Polymorphisms at GSTM 1, GSTP 1, GSTT 1 Detoxification Genes Loci and Risk of Breast Cancer in Kazakhstan Population
ABSTRACT

Associations of null polymorphism (copy number variation) of detoxification genes GSTM1, GSTT1 and GSTP1 (at rs2495636, 105 Ile/Val) with the breast cancer (BC) were assessed in two main ethnic groups of the Republic of Kazakhstan (Kazakhs and Russians). Total number of patients was 181, and of controls 397. Statistically significant difference was observed between BC patients and healthy individuals in alleles frequency (χ2 = 4.89, р = 0.007) of GSTP1 gene at rs2495636 (105 Ile/Val) among the Kazakhs ethnic group. Difference in genotypes distribution (χ2 =5.26, р = 0.076) at this site is approximating to be statistically significant. In the Russian group, no differences were found in genotypes and alleles atrs 2495636 of GSTP1 gene between cases and controls. There was no significant difference between null polymorphism (copy number variation) of GSTM1 and GSTT1 genes among cases and controls in both ethnic groups.


Cite this paper
Balmukhanov, T. , Khanseitova, A. , Nigmatova, V. , Ashirbekov, E. , Talaeva, S. and Aitkhozhina, N. (2013) Polymorphisms at GSTM 1, GSTP 1, GSTT 1 Detoxification Genes Loci and Risk of Breast Cancer in Kazakhstan Population. Advances in Breast Cancer Research, 2, 114-118. doi: 10.4236/abcr.2013.24019.
References
[1]   R. C. Strange, J. T. Lear and A. A. Fryer, “Glutathione S-Transferase Polymorphisms: Influence on Susceptibility to Cancer,” Chemico-Biological Interactions, Vol. 111-112, 1998, pp. 351-364. http://dx.doi.org/10.1016/S0009-2797(97)00172-5

[2]   T. R. Rebbeck, “Molecular Epidemiology of the Human Glutathione S-Transferase Genotypes GSTM1 and GSTT1 in Cancer Susceptibility,” Cancer Epidemiology, Biomarkers & Prevention, Vol. 6, No. 9, 1997, pp. 733-743.

[3]   V. Nazar-Stewart, A. G. Motulsky and D. L. Eaton, “The Glutathione S-Transferase mu Polymorphism as a Marker for Susceptibility to Lung Carcinoma,” Cancer Research, Vol. 53, No. S10, 1993, pp. 2313-2318.

[4]   J. K. Wiencke, K. T. Kelsey, R. A. Lamela and W. A. Toscano Jr., “Human Glutathione S-Transferase Deficiency as a Marker of Susceptibility to Epoxide-Induced Cytogenetic Damage,” Cancer Research, Vol. 50, No. 5, 1990, pp. 1585-1590.

[5]   W. G. Nelson, A. M. De Marzo and T. L. DeWeese, “The Molecular Pathogenesis of Prostate Cancer: Implications for Prostate Cancer Prevention,” Urology, Vol. 57, No. S4, 2001, pp. 39-45. http://dx.doi.org/10.1016/S0090-4295(00)00939-0

[6]   F. Ali-Osman, O. Akande and G. Antoun, “Molecular Cloning, Characterization, and Expression in Escherichia coli of Full-Length cDNAs of Three Human Glutathione S-Transferase Pi Gene Variants. Evidence for Differential Catalytic Activity of the Encoded Proteins,” The Journal of Biological Chemistry, Vol. 272, No. 15, 1997, pp. 10004-10012. http://dx.doi.org/10.1074/jbc.272.15.10004

[7]   K. Sundberg, A. S. Johansson and G. Stenberg, “Differences in the Catalytic Efficiencies of Allelic Variants of Glutathione Transferase P1-1 towards Carcinogenic Diol Epoxides of Polycyclic Aromatic Hydrocarbons,” Carcinogenesis, Vol. 19, No. 3, 1998, pp. 433-436. http://dx.doi.org/10.1093/ carcin/19.3.433

[8]   S. K. Park, D. S. Yim, K. S. Yoon, I. M. Choi, J. Y. Choi, K. Y. Yoo, D. Y. Noh, K. J. Choe, S. H. Ahn, A. Hirvonen and D. Kang, “Combined Effect of GSTM1, GSTT1, and COMT Genotypes in Individual Breast Cancer Risk,” Breast Cancer Research and Treatment, Vol. 88, No. 1, 2004, pp. 55-62. http://dx.doi.org/10.1007/s10549-004-0745-x

[9]   K. Mitrunen, N. Jourenkova, V. Kataja, M. Eskelinen, V. M. Kosma, S. Benhamou, H. Vainio, M. Uusitupa and A. Hirvonen, “Glutathione S-Transferase M1, M3, P1, and T1 Genetic Polymorphisms and Susceptibility to Breast Cancer,” Cancer Epidemiology, Biomarkers & Prevention, Vol. 10, No. 3, 2001, pp. 229-236.

[10]   A. L. Oliveira, F. F. Rodrigues, R. E. Santos, T. Aoki, M. N. Rocha, C. A. Longui and M. B. Melo, “GSTT1, GSTM1, and GSTP1 Polymorphisms and Chemotherapy Response in Locally Advanced Breast Cancer,” Genetics and Molecular Research, Vol. 9, No. 2, 2010, pp. 1045-1053. http://dx.doi.org/10.4238/vol9-2gmr726

[11]   T. Pongtheerat, M. Treetrisool and W. Purisa, “Glutathione S-Transferase Polymorphisms in Breast Cancers of Thai Patients,” Asian Pacific Journal of Cancer Prevention, Vol. 10, No. 1, 2009, pp. 127-132.

[12]   B. Kiran, M. Karkucak, H. Ozan, T. Yakut, K. Ozerkan, S. Sag and M. J. Ture, “GST (GSTM1, GSTT1, and GSTP1) Polymorphisms in the Genetic Susceptibility of Turkish Patients to Cervical Cancer,” Journal of Gynecologic Oncology, Vol. 21, No. 3, 2010, pp. 169-173. http://dx.doi.org/10.3802/jgo. 2010.21.3.169

[13]   L. C. Sakoda, C. R. Blackston, K. Xue, J. A. Doherty, R. M. Ray, M. G. Lin, H. Stalsberg, D. L. Gao, Z. Feng, D. B. Thomas and C. Chen, “Glutathione S-Transferase M1 and P1 Polymorphisms and Risk of Breast Cancer and Fibrocystic Breast Conditions in Chinese Women,” Breast Cancer Research and Treatment, Vol. 109, No. 1, 2008, pp. 143-155. http://dx.doi.org/10.1007/s10549-007-9633-5

[14]   B. O. Van Emburgh, J. J. Hu, E. A. Levine, L. J. Mosley, N. D. Perrier, R. I. Freimanis, G. O. Allen, P. Rubin, G. B. Sherrill, C. S. Shaw, L. A. Carey, L. R. Sawyer and M. S. Miller, “Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and Susceptibility to Breast Cancer,” Oncology Report, Vol. 19, No. 5, 2008, pp. 1311-1321.

[15]   D. Xu, S. Yan, J. Yin and P. Zhang, “Null Genotype of GSTT1 Contributes to Colorectal Cancer Risk in Asian Populations: Evidence from a Meta-Analysis,” Asian Pacific Journal of Cancer Prevention, Vol. 12, No. 9, 2011, pp. 2279-2284.

[16]   M. I. Khan, S. Micheal, F. Akhtar, W. Ahmed, B. Ijaz, A. Ahmed and R. Qamar, “The Association of Glutathione S-Transferase GSTT1 and GSTM1 Gene Polymorphism with Pseudoexfoliative Glaucoma in a Pakistani Population,” Molecular Vision, Vol. 26, No. 16, 2010, pp. 2146-2152.

[17]   A. C. Ramalhinho, J. A. Fonseca-Moutinho and L. A. Breitenfeld Granadeiro, “Positive Association of Polymorphisms in Estrogen Biosynthesis Gene, CYP19A1, and Metabolism, GST, in Breast Cancer Susceptibility,” DNA and Cell Biology, Vol. 31, No. 6, 2012, pp. 1100-1106. http://dx.doi.org/ 10.1089/dna.2011.1538

[18]   F. D. Vogl, E. Taioli, C. Maugard, W. Zheng, L. F. Pinto, C. Ambrosone, F. F. Parl, V. Nedelcheva-Kristensen, T. R. Rebbeck, P. Brennan and P. Boffetta, “Glutathione S-Transferases M1, T1, and P1 and Breast Cancer: A Pooled Analysis,” Cancer Epidemiology, Biomarkers & Prevention, Vol. 13, No. 9, 2004, pp. 1473-1479.

 
 
Top